1. Home
  2. DLXY vs ENVB Comparison

DLXY vs ENVB Comparison

Compare DLXY & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delixy Holdings Limited Ordinary Shares

DLXY

Delixy Holdings Limited Ordinary Shares

N/A

Current Price

$1.76

Market Cap

7.3M

Sector

N/A

ML Signal

N/A

Logo Enveric Biosciences Inc.

ENVB

Enveric Biosciences Inc.

HOLD

Current Price

$1.40

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLXY
ENVB
Founded
2007
1994
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
6.7M
IPO Year
2024
2000

Fundamental Metrics

Financial Performance
Metric
DLXY
ENVB
Price
$1.76
$1.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 817.1K
57.2K
Earning Date
11-03-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $39,914,675.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.23
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.34
$1.17
52 Week High
$4.25
$795.00

Technical Indicators

Market Signals
Indicator
DLXY
ENVB
Relative Strength Index (RSI) 54.67 45.32
Support Level $0.39 $1.37
Resistance Level $3.20 $1.53
Average True Range (ATR) 0.33 0.10
MACD -0.10 0.00
Stochastic Oscillator 10.53 32.92

Price Performance

Historical Comparison
DLXY
ENVB

About DLXY Delixy Holdings Limited Ordinary Shares

Delixy Holdings Ltd a holding company. Through its subsidiary, it is principally engaged in the trading of oil-related products, which are broadly categorized into crude oil and oil-based products, including naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. These products are traded across multiple countries in Southeast Asia, East Asia, and the Middle East, and the Group has established a presence in the oil trading markets in these countries. The majority of the Group's revenue is generated from the trading of crude oil. Geographically, it derives maximum revenue from its business in East Asia.

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Share on Social Networks: